[REGN] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
08-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- 33.83%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 8,497,100 7,863,400 6,710,800 5,872,227 4,860,427 4,103,728 2,819,557 20.16%
PBT 3,810,400 2,429,100 2,553,500 2,078,511 1,329,815 1,225,097 775,747 30.34%
Tax 297,200 313,300 109,100 880,000 434,293 589,041 427,673 -5.88%
NP 3,513,200 2,115,800 2,444,400 1,198,511 895,522 636,056 348,074 46.95%
Tax Rate -7.80% -12.90% -4.27% -42.34% -32.66% -48.08% -55.13% -
Total Cost 4,983,900 5,747,600 4,266,400 4,673,716 3,964,905 3,467,672 2,471,483 12.38%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 41.35 26.91 36.42 20.41 18.42 15.50 12.34 22.30%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 32.65 19.38 21.29 11.27 8.55 6.17 3.36 46.02%
EPS Diluted 30.52 18.46 21.29 10.34 7.70 5.52 2.98 47.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.